Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market
Key Points15,000 shares were sold for a transaction value of approximately $928,950 at a weighted average price of around $61.93 per share on Feb. 5, 2026...
Nasdaq News: Markets·13h ago